Commonwealth Equity Services
ADPT icon

Commonwealth Equity Services’s Adaptive Biotechnologies ADPT Stock Holding History

Commonwealth Equity Services’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$273K Sell
12,728
-19,289
-60% -$296K ﹤0.01% 3841
2026
Q1 		$444K Sell
32,017
-7,437
-19% -$118K ﹤0.01% 3314
2025
Q4 		$641K Sell
39,454
-2,097
-5% -$34.2K ﹤0.01% 2963
2025
Q3 		$622K Buy
41,551
+5,008
+14% +$61K ﹤0.01% 2996
2025
Q2 		$426K Sell
36,543
-9,500
-21% -$86.3K ﹤0.01% 3288
2025
Q1 		$342K Buy
46,043
+415
+0.9% +$3.19K ﹤0.01% 3379
2024
Q4 		$274K Buy
45,628
+50
+0.1% +$276 ﹤0.01% 3498
2024
Q3 		$233K Sell
45,578
-50
-0.1% -$218 ﹤0.01% 3565
2024
Q2 		$165K Sell
45,628
-333
-0.7% -$1.06K ﹤0.01% 3695
2024
Q1 		$148K Sell
45,961
-327
-0.7% -$1.26K ﹤0.01% 3715
2023
Q4 		$227K Sell
46,288
-8,976
-16% -$41K ﹤0.01% 3405
2023
Q3 		$301K Buy
55,264
+3,498
+7% +$23.1K ﹤0.01% 3033
2023
Q2 		$347K Buy
51,766
+1,800
+4% +$13.4K ﹤0.01% 2922
2023
Q1 		$441K Sell
49,966
-5,035
-9% -$44.4K ﹤0.01% 2663
2022
Q4 		$420K Buy
55,001
+1,300
+2% +$10.1K ﹤0.01% 2608
2022
Q3 		$382K Buy
53,701
+1,225
+2% +$11.5K ﹤0.01% 2626
2022
Q2 		$424K Sell
52,476
-1,390
-3% -$12.2K ﹤0.01% 2537
2022
Q1 		$747K Buy
53,866
+6,701
+14% +$105K ﹤0.01% 2215
2021
Q4 		$1.32M Sell
47,165
-14,901
-24% -$457K ﹤0.01% 1792
2021
Q3 		$2.11M Sell
62,066
-2,743
-4% -$99.2K 0.01% 1397
2021
Q2 		$2.65M Buy
64,809
+22,653
+54% +$881K 0.01% 1244
2021
Q1 		$1.7M Sell
42,156
-225
-0.5% -$12.2K ﹤0.01% 1442
2020
Q4 		$2.5M Sell
42,381
-894
-2% -$46.1K 0.01% 1099
2020
Q3 		$2.1M Buy
43,275
+1,116
+3% +$46.9K 0.01% 1067
2020
Q2 		$2.04M Buy
42,159
+36
+0.1% +$1.31K 0.01% 1020
2020
Q1 		$1.17M Buy
+42,123
New +$1.17M 0.01% 1178

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Commonwealth Equity Services's ADPT Position: Q2 2026 in Review

Commonwealth Equity Services reduced its Adaptive Biotechnologies (ADPT) stake by 60% in Q2 2026, selling an estimated $296K and leaving 12,728 shares worth $273K. The position accounts for ﹤0.01% of the portfolio, ranked #3841.

Commonwealth Equity Services first reported a position in ADPT in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.65M in Q2 2021. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Commonwealth Equity Services held 12,728 shares of Adaptive Biotechnologies worth $273K as of Q2 2026.
  • Commonwealth Equity Services sold 19,289 Adaptive Biotechnologies shares in Q2 2026, an estimated $296K.
  • Adaptive Biotechnologies made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #3841 holding.
  • Commonwealth Equity Services first reported a position in Adaptive Biotechnologies in Q1 2020 and has held it in 26 quarters since.
  • Commonwealth Equity Services's Adaptive Biotechnologies position peaked at $2.65M in Q2 2021.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.